Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Tengrinews.kz - Each year, skywatchers in Kazakhstan get the chance to witness one of nature’s most dazzling displays — the ...